• Home
• About Me
• Contact Me
• Archives
• Free-CE Links
• Pharmacy Blogs
• Terms of Use

Subscribe

• Drug Topics
• FDA: MedWatch
• FDA: News/Recalls
• Medical News
• Pharmacist News
• PharmAZy News

Patients Are Asking: Choosing the Correct Test Strip for a Blood Glucose Meter

FDA is aware of cases where patients have used LifeScan OneTouch Ultra test strips with their Abbott Precision Xtra blood glucose meters. As a result, the meters recorded lower-than-expected blood glucose levels, which can have serious clinical ...

Preventing Medical Errors: Mistakenly Swallowing Inhaler Capsules

FDA has issued an advisory about the danger of mistakenly swallowing Spiriva (tiotropium bromide inhalation powder) and Foradil (formoterol fumarate inhalation powder) inhalation capsules. These capsules are intended to be used with inhalation devic...

Recalls and Safety Alerts: Information on Mortality Rates with the AneuRx Stent Graft System

In a recent Public Health Notification, FDA informed healthcare professionals about new data on mortality rates associated with the AneuRx Stent Graft System. This endovascular graft, made by Medtronic, is used as an alternative to open surgery in p...

Recalls and Safety Alerts: Hepatotoxicity with Prezista

FDA and Tibotec Therapeutics are alerting healthcare professionals about the risk of hepatotoxicity associated with the antiretroviral drug Prezista (darunavir). Prezista, co-administered with ritonavir and other antiretroviral agents, is used to tr...

Recalls and Safety Alerts: New Instructions for Using Talecris IG Syringes

Talecris Biotherapeutics has revised the directions for administering some of the company's immune globulin products -- ones that come in uncalibrated prefilled 2 mL syringes with fixed needles. The products are HyperRAB™ S/D , which is an anti-rabi...

Recalls and Safety Alerts: Updated Labeling Changes for Tamiflu and Relenza

Roche Laboratories has updated information on neuropsychiatric events for Tamiflu (oseltamivir phosphate), a drug that's used to treat or prevent influenza in patients 1 year and older. The revised labeling reminds practitioners that some patients...

Recalls and Safety Alerts: Liver Injury with Tysabri

Biogen Idec and Elan Pharmaceuticals are warning healthcare professionals about reports of clinically significant liver injury in patients taking Tysabri (natalizumab). Tysabri is a monoclonal antibody used to treat certain patients with relapsing f...

Recalls and Safety Alerts: Unsafe Use of Extended-Release Tussionex Suspension

FDA is cautioning healthcare professionals, patients and caregivers about the unsafe use of Tussionex Pennkinetic Extended-Release Suspension. This product is a long-acting cough suppressant containing hydrocodone, a narcotic antitussive, and chlorp...

New Medical Products: FDA Licenses New Hemophilia Treatment

FDA recently licensed a new treatment for hemophilia A called Xyntha. Xyntha, which is made by Wyeth Pharmaceuticals, is a genetically engineered version of factor VIII, a protein essential for blood clotting that is decreased or absent in patients ...

Greener Urban Areas May Reduce Childhood Asthma Rates

NEW YORK -- Young children who live in city neighborhoods with tree-lined streets are less likely to develop asthma, but the actual protective factor remains unknown, researchers said.

Next Page »

eNews & Updates

SPONSORSHIP: Upromise College Savings Plan

Login | The Arizona Pharmacist | Copyright © 2007-08 PharmAZy Services, LLC